• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cost-control programs boost OEC earnings

Article

OEC Medical Systems reported a strong increase in net income forits 1995 fiscal year (end-December), although revenues were uponly slightly compared with 1994. OEC, of Salt Lake City, attributedthe earnings growth to improved profit margins that resulted

OEC Medical Systems reported a strong increase in net income forits 1995 fiscal year (end-December), although revenues were uponly slightly compared with 1994. OEC, of Salt Lake City, attributedthe earnings growth to improved profit margins that resulted fromcost-control programs.

For the year, OEC had revenues of $101.5 million, up 3% comparedwith $98.2 million in sales the year before. The company saidinternational sales were a bright spot, as it saw a 125% increasein revenues. In the U.S., however, the ongoing consolidation ofthe healthcare industry hurt sales. Orders in 1995 were levelwith those of 1994, but higher discounting resulted in lower revenues,according to OEC chief executive Ruediger Naumann-Etienne.

Net income for the year increased sharply. OEC registered earningsof $11.8 million, up 36% over the $8.7 million reported in theyear before. Naumann-Etienne said operating profit increased asthe company focused on improving manufacturing efficiencies andon controlling costs.

For the fourth quarter of 1995, OEC had net income of $3.4million on sales of $27.1 million, compared with net income of$3.1 million and sales of $28.2 million in the fourth quarterof 1994.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.